These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 22569435

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients.
    Poulia KA, Panagiotakos DB, Tourlede E, Rezou A, Stamatiadis D, Boletis J, Zampelas A.
    J Ren Nutr; 2011 Nov; 21(6):479-84. PubMed ID: 21439849
    [Abstract] [Full Text] [Related]

  • 25. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A, Ustün H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A.
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
    An WS, Kim SE, Kim KH, Lee S, Park Y, Kim HJ, Vaziri ND.
    J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients.
    Perunicic-Pekovic GB, Rasic ZR, Pljesa SI, Sobajic SS, Djuricic I, Maletic R, Ristic-Medic DK.
    Nephrology (Carlton); 2007 Aug; 12(4):331-6. PubMed ID: 17635746
    [Abstract] [Full Text] [Related]

  • 30. The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.
    Gharekhani A, Khatami MR, Dashti-Khavidaki S, Razeghi E, Noorbala AA, Hashemi-Nazari SS, Mansournia MA.
    Eur J Clin Pharmacol; 2014 Jun; 70(6):655-65. PubMed ID: 24643636
    [Abstract] [Full Text] [Related]

  • 31. Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients.
    Lemos JR, Alencastro MG, Konrath AV, Cargnin M, Manfro RC.
    Nutr Res; 2012 Dec; 32(12):921-7. PubMed ID: 23244537
    [Abstract] [Full Text] [Related]

  • 32. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome.
    Yang J, Li XP, Zhao SP, Li J, Li JD, Xie XM.
    Clin Chim Acta; 2006 Jun; 368(1-2):183-7. PubMed ID: 16472797
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serum CRP levels in pre-dialysis patients.
    Razeghi E, Parkhideh S, Ahmadi F, Khashayar P.
    Ren Fail; 2008 Jun; 30(2):193-8. PubMed ID: 18300120
    [Abstract] [Full Text] [Related]

  • 35. Short-term effect of simvastatin treatment on inflammatory parameters in peritoneal dialysis patients.
    Sezer MT, Katirci S, Demir M, Erturk J, Adana S, Kaya S.
    Scand J Urol Nephrol; 2007 Jun; 41(5):436-41. PubMed ID: 17853009
    [Abstract] [Full Text] [Related]

  • 36. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
    Liang M, Wang L, Hou FF, Liu J, Liu ZQ, Tian JW.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
    [Abstract] [Full Text] [Related]

  • 37. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO, Pocan B, Borazan A, Ucar E, Kuvandik G, Ilikhan S, Demircan N, Ozer C, Kadayifci S.
    Ren Fail; 2008 Aug; 30(2):219-25. PubMed ID: 18300125
    [Abstract] [Full Text] [Related]

  • 38. The evaluation of increase in hemodialysis frequency on C-reactive protein levels and nutritional status.
    Rashidi AA, Soleimani AR, Nikoueinejad H, Sarbolouki S.
    Acta Med Iran; 2013 Mar 16; 51(2):119-24. PubMed ID: 23585319
    [Abstract] [Full Text] [Related]

  • 39. C-reactive protein, interleukin-6, and tumor necrosis factor-alpha levels in overweight and healthy adults.
    Chaikate S, Harnroongroj T, Chantaranipapong Y, Puduang S, Mahaisiriyodom A, Viroonudomphol D, Singhasivanon P, Schelp FP, Tornee S, Tribunyatkul S, Changbumrung S.
    Southeast Asian J Trop Med Public Health; 2006 Mar 16; 37(2):374-81. PubMed ID: 17125002
    [Abstract] [Full Text] [Related]

  • 40. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I, Smaoui W, Hamida FB, Ouniss M, Aderrahim E, Hedri H, Elyounsi F, Maiz HB, Abdallah TB, Kheder A.
    Saudi J Kidney Dis Transpl; 2010 Jan 16; 21(1):59-62. PubMed ID: 20061694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.